News

FDA crackdown on off-brand Ozempic products set to take effect, threatening supply and access for many
The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...
Pulmonology Advisor23h
FDA Halts Sale of Off-Brand Ozempic and Other GLP-1 Drugs
Compounded GLP-1s are no longer to be sold following the FDA announcement that the shortage of semaglutide and tirzepatide ended.
FDA cracking down on Ozempic copycats, potentially slimming options for consumers
The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and ...
NewsChannel 5 Nashville7h
Is your alternate way of getting Ozempic safe?
We've all heard about Ozempic — a medication that treats diabetes but is largely used to lose weight. But not everyone does ...
Seattle weight loss patients fret over FDA limits on off-brand drugs
As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...
The New York Sun5d
Millions of Americans Face Sticker Shock From Weight Loss Drugs as FDA Bars Production of Cheaper Versions of Ozempic, Others
Compounding pharmacies, that produced the weight loss drugs at a fraction of their brand name price, are being forced to stop ...
Verywell Health on MSN8d
What Are ‘Ozempic Babies’? How Weight Loss Drugs Affect Fertility
Some say that Ozempic can lead to surprise pregnancies, referred to as "Ozempic babies," by increasing fertility. Learn what ...
Junk food is addictive. Drugs like Ozempic treat addiction. But when will we tackle Big Food like we did Big Tobacco?
A former head of the US Food and Drug Administration cut his body fat in half using GLP-1 drugs. In his book, he compares the ...
Becker's Hospital Review11d
Companies sidestep FDA deadline on Ozempic copies
An FDA deadline instructing compounding pharmacies and telehealth companies to stop selling compounded versions of Ozempic and Zepbound has not stopped the copycat market, The Wall Street Journal ...